Arega Medical, which started its activities in 2021, is the leading R&D healthcare company that focusses on identification, development and commercialization of repurposed drugs for untreatable diseases. We have a diversified clinical late-stage R&D portfolio of repurposed drugs in high unmet need diseases.
We aim to address the society need for sustainable healthcare as well as patient’s needs for effective, safe and affordable therapies.
We have the conviction and the vision to disrupt the pharmaceutical market.
Repurposed drugs offer a more efficient and cost-effective development path. We believe that the savings this brings to society, should be fed into the healthcare system. Our promise is socially responsible pricing to support sustainable healthcare.
Precision medicine by network pharmacology is a revolution in medicine. Big data allows mapping of underlying disease mechanisms and design targeted drug combinations, treating the underlying disease processes in stead of merely providing symptom relief. By combining drugs with companion diagnostics , we will be able to offer precision treatments to patients suffering from untreatable complex diseases.
We are all about: